PGNY
Progyny, Inc.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
23.23
PEG
3.02
P/B
2.74
P/S
1.05
EV/EBITDA
13.01
DCF Value
$23.13
FCF Yield
13.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
23.6%
Operating Margin
6.6%
Net Margin
4.5%
ROE
11.4%
ROA
8.2%
ROIC
9.6%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $318.4M | $12.5M | $0.14 |
| FY 2025 | $1.29B | $58.5M | $0.65 |
| Q3 2025 | $313.3M | $13.9M | $0.15 |
| Q2 2025 | $332.9M | $17.1M | $0.19 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
0.99
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.